Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

China flag China · Delayed Price · Currency is CNY
34.10
-0.29 (-0.84%)
Mar 11, 2026, 11:25 AM CST
27.33%
Market Cap 3.64B
Revenue (ttm) 1.10B
Net Income (ttm) 120.51M
Shares Out 105.91M
EPS (ttm) 1.15
PE Ratio 29.91
Forward PE n/a
Dividend 0.20 (0.59%)
Ex-Dividend Date Sep 16, 2025
Volume 1,194,300
Average Volume 5,890,314
Open 34.39
Previous Close 34.39
Day's Range 34.05 - 34.55
52-Week Range 24.05 - 42.88
Beta -0.26
RSI 44.41
Earnings Date Apr 28, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China. [Read more]

Sector Healthcare
Founded 1997
Employees 933
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002864
Full Company Profile

Financial Performance

In 2024, SHE:002864's revenue was 973.86 million, a decrease of -0.71% compared to the previous year's 980.83 million. Earnings were 120.27 million, an increase of 8.91%.

Financial Statements

News

There is no news available yet.